BTK Inhibitors in the Treatment of MS MStranslate December 12, 2023 Clinical Trials, Research, Treatments What is Bruton’s Tyrosine Kinase (BTK)? Bruton’s Tyrosine Kinase, or BTK, is an enzyme in the body that plays a role in the activity of B...
Neural Stem Cell Transplantation for Progressive MS MStranslate March 28, 2023 Research, Stem Cells, Treatments 1 Comment Research Summary: Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study The treatment of...
Treating Fatigue in Multiple Sclerosis MStranslate July 20, 2021 Fatigue, Research, Symptoms, Treatments Fatigue. It is one of the most commonly reported symptoms by people living with multiple sclerosis (MS). Not only do many people experience it,...
mRNA Vaccines & Their Potential in MS MStranslate January 15, 2021 Research, Treatments, Videos Recently published research from the University Medical Center of the Johannes Gutenberg University has looked at the use of an mRNA vaccine as a...
MS Research in the New Millennium: 2000 – 2020 MStranslate July 23, 2020 Research, Treatments It’s been 20 years since the world nervously welcomed the new millennium. Let’s look back on those two decades and examine the major...
Research Reflections: Siponimod Trial Results MStranslate November 21, 2019 Clinical Trials, Research, Treatments 1 Comment In April 2018, we published the below video to our Facebook page, exploring and discussing the results of the Phase III trial of Mayzent (siponimod)....
Emerging Themes in Multiple Sclerosis Research MStranslate November 5, 2019 Opinion, Research, Videos On a recent visit to Melbourne, Australia, Prof Amit Bar-Or (University of Pennsylvania) sat down with Prof Trevor Kilpatrick (University of...
ECTRIMS 2019: Final Thoughts From Stockholm MStranslate September 13, 2019 Dr Travis Stiles, ECTRIMS, Research ECTRIMS 2019 has officially ended. It is safe to say that it was a huge three days and I am exhausted! I really hope that you have enjoyed the...
FDA Approves Second Drug For Active SPMS MStranslate April 1, 2019 Research, Treatments Late last week, it was announced that Mavenclad (cladribine) received US FDA approval for the treatment of adults living with relapsing multiple...
New Treatment Approved for Active SPMS MStranslate March 27, 2019 Research, Treatments 1 Comment It was announced earlier today that Mayzent (siponimod) has received US FDA approval for the treatment of adults living with relapsing multiple...